Complete the form to get personalized recommendations
Recommendations will appear here based on your selections
Drug | Form & Typical Dose | Key Indications | Pros | Cons |
---|---|---|---|---|
Duphaston (dydrogesterone) | Tablet 10 mg – 2–3 times daily | Luteal-phase support, PMS, recurrent miscarriage | Low androgenic activity, good oral bioavailability | Requires multiple daily tablets for some regimens |
Norethisterone | Tablet 5–10 mg – once daily | Heavy menstrual bleeding, endometriosis | Simple once-daily dosing, inexpensive | Higher risk of acne, mood changes, VTE in smokers |
Medroxyprogesterone acetate (MPA) | Tablet 10 mg – once daily OR 150 mg IM injection every 3 months | HRT, certain cancers, amenorrhea | Long-acting injection option, strong endometrial protection | Weight gain, metabolic effects, higher clot risk |
Micronized progesterone | Soft-gel 100–200 mg – twice daily | Menopausal hormone therapy, sleep aid | Identical to natural progesterone, minimal androgenicity | Twice-daily dosing, higher cost |
Drospirenone | Tablet 3 mg – once daily (usually combined with estrogen) | Combined oral contraceptive, acne, water-retention | Anti-mineralocorticoid effect reduces bloating | Increased clot risk when combined with estrogen, potassium loss |
Vaginal progesterone | Gel 90 mg – once daily (insertion) | Luteal-phase support in IVF, refractory progesterone deficiency | Direct uterine delivery, bypasses liver | Messy application, may cause local irritation |
If you’ve ever stared at a prescription label wondering why Duphaston looks different from the other progesterone pills, you’re not alone. The market is crowded with synthetic progestins, each promising relief from menstrual irregularities, infertility, or menopausal symptoms. This guide breaks down the chemistry, dosing, pros, and cons of the most common alternatives so you can match a drug to your specific health goal.
First, let’s set the stage with a clear definition of the star of the show.
Duphaston is a brand‑name tablet that contains dydrogesterone, a synthetic hormone structurally similar to natural progesterone. It was introduced in the 1960s and is approved for luteal‑phase support, treatment of menstrual disturbances, and prevention of recurrent miscarriage.
Now, how does dydrogesterone stack up against the rest of the progestin family?
All progestins interact with the progesterone receptor, but their side‑effect profiles depend on how closely they resemble the body’s own hormone. Below are the six most frequently prescribed alternatives, each with a brief, micro‑tagged snapshot.
Norethisterone is an oral synthetic progestin used for heavy periods, endometriosis, and contraception. Its chemical backbone includes an ethinyl group, giving it strong androgenic activity that can cause acne or mood changes.
Medroxyprogesterone acetate (MPA) is a depot‑injectable or oral formulation often employed in hormone‑replacement therapy (HRT) and certain cancers. MPA provides robust endometrial protection but is linked to higher incidents of weight gain and lipid alterations.
Micronized progesterone (soft‑gel or oral capsules) is a bioidentical form derived from plant sterols. Because it is chemically identical to endogenous progesterone, it has a favorable side‑effect profile but suffers from poor oral bioavailability, often requiring twice‑daily dosing.
Drospirenone is a newer generation progestin incorporated in many combined oral contraceptives. It acts as a progesterone receptor agonist and an anti‑mineralocorticoid, reducing water retention, yet may increase the risk of thromboembolism in smokers.
Vaginal progesterone (e.g., Crinone gel) is administered directly to the uterus, bypassing hepatic metabolism. It’s favored for luteal‑phase support in assisted reproduction, though insertion can be messy for some users.
When comparing any hormone, the “feel” matters as much as the lab data. Below is a concise matrix that translates clinical findings into everyday language.
Drug | Common Mild Effects | Serious Risks |
---|---|---|
Duphaston (dydrogesterone) | Headache, mild nausea | Very low thrombotic risk |
Norethisterone | Acne, mood swings, breast tenderness | Increased VTE risk in smokers |
Medroxyprogesterone acetate | Weight gain, fluid retention | Higher VTE and metabolic syndrome incidence |
Micronized progesterone | Drowsiness, mild bloating | Rare hepatic enzyme elevation |
Drospirenone | Reduced bloating, mild potassium loss | Elevated clot risk, especially with estrogen |
Vaginal progesterone | Local irritation, discharge | Negligible systemic risks |
Clinical guidelines point to three scenarios where dydrogesterone shines:
If you fall into any of those categories and value a low‑androgen profile, Duphaston is often the first‑line choice.
Below is a side‑by‑side look at the six alternatives, focusing on dosage convenience, cost, and evidence‑based effectiveness for common indications.
Drug | Form & Typical Dose | Key Indications | Pros | Cons |
---|---|---|---|---|
Duphaston (dydrogesterone) | Tablet 10mg - 2‑3times daily | Luteal‑phase support, PMS, recurrent miscarriage | Low androgenic activity, good oral bioavailability | Requires multiple daily tablets for some regimens |
Norethisterone | Tablet 5‑10mg - once daily | Heavy menstrual bleeding, endometriosis | Simple once‑daily dosing, inexpensive | Higher risk of acne, mood changes, VTE in smokers |
Medroxyprogesterone acetate (MPA) | Tablet 10mg - once daily OR 150mg IM injection every 3months | HRT, certain cancers, amenorrhea | Long‑acting injection option, strong endometrial protection | Weight gain, metabolic effects, higher clot risk |
Micronized progesterone | Soft‑gel 100‑200mg - twice daily | Menopausal hormone therapy, sleep aid | Identical to natural progesterone, minimal androgenicity | Twice‑daily dosing, higher cost |
Drospirenone | Tablet 3mg - once daily (usually combined with estrogen) | Combined oral contraceptive, acne, water‑retention | Anti‑mineralocorticoid effect reduces bloating | Increased clot risk when combined with estrogen, potassium loss |
Vaginal progesterone | Gel 90mg - once daily (insertion) | Luteal‑phase support in IVF, refractory progesterone deficiency | Direct uterine delivery, bypasses liver | Messy application, may cause local irritation |
Price can be a make‑or‑break factor, especially for long‑term therapy. Approximate Australian retail prices (2025) are:
While Duphaston isn’t the cheapest option, its targeted efficacy often offsets the need for adjunct medications or additional doctor visits.
Regardless of the chosen progestin, keep these safety basics in mind:
This flowchart helps you land on a drug that aligns with both your clinical need and lifestyle.
Because both are oral progestins, most clinicians recommend a brief 48‑hour gap to assess any lingering side‑effects, then start Duphaston at the usual dose. Always confirm with your prescriber, especially if you have hormone‑sensitive conditions.
Limited data suggest minimal transfer into breast milk, and most lactation experts consider short‑term use (up to 4weeks) acceptable. Long‑term exposure should be discussed with a pediatrician.
Its oral bioavailability is only about 10‑15%. Splitting the dose maintains steadier blood levels and reduces night‑time drowsiness.
Drospirenone mimics the natural hormone progesterone *and* blocks aldosterone, which helps cut water retention-useful for women who experience bloating on combined pills.
Generally not needed; combining two progestins can raise the risk of side‑effects without added benefit. Your fertility specialist may prescribe one or the other based on protocol.
Take a moment to map your specific need onto the decision tree above. Then, schedule a short appointment with your GP or specialist armed with these talking points:
Armed with a side‑by‑side comparison, you’ll be in a better position to choose a progesterone that fits your body and budget.
kevin joyce
6 October, 2025 . 19:44 PM
When you unpack the pharmacodynamics of dydrogesterone, you realize it isn’t just another synthetic progestin; it mimics the endogenous hormone with a molecular finesse that reduces androgenic spill‑over, a nuance often lost in lay discussions. The oral bioavailability, hovering around 70‑80 %, ensures consistent plasma levels without the hepatic first‑pass degradation that plagues many counterparts. Moreover, its receptor affinity profile translates into a cleaner side‑effect spectrum, especially for patients sensitive to acne or mood fluctuations. In the grand schema of reproductive endocrinology, Duphaston sits at the intersection of efficacy and tolerability, a sweet spot that warrants its continued prominence in luteal‑phase support protocols.
For clinicians wrestling with the trade‑off between convenience and mechanistic fidelity, this agent offers a pragmatic solution that aligns with both evidence‑based practice and patient‑centered care.